Allegra Adele Petti, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 13 | 2024 | 3602 | 1.070 |
Why?
|
Sulfur | 3 | 2012 | 163 | 0.580 |
Why?
|
Methionine | 4 | 2012 | 569 | 0.530 |
Why?
|
Saccharomyces cerevisiae | 8 | 2012 | 2698 | 0.520 |
Why?
|
Sequence Analysis, RNA | 4 | 2019 | 2005 | 0.500 |
Why?
|
Bacillus Phages | 1 | 2013 | 12 | 0.460 |
Why?
|
Myelodysplastic Syndromes | 5 | 2024 | 1394 | 0.420 |
Why?
|
Gene Expression Regulation, Fungal | 6 | 2012 | 499 | 0.420 |
Why?
|
Host-Parasite Interactions | 1 | 2013 | 301 | 0.380 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2012 | 317 | 0.360 |
Why?
|
Bacillus subtilis | 1 | 2013 | 351 | 0.360 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2380 | 0.330 |
Why?
|
RNA | 1 | 2019 | 2722 | 0.330 |
Why?
|
Saccharomyces cerevisiae Proteins | 6 | 2012 | 1854 | 0.320 |
Why?
|
Cell Division | 2 | 2013 | 4463 | 0.310 |
Why?
|
Glioblastoma | 5 | 2024 | 3484 | 0.310 |
Why?
|
Interleukin-15 | 3 | 2024 | 183 | 0.280 |
Why?
|
Viral Proteins | 1 | 2013 | 1802 | 0.270 |
Why?
|
Azacitidine | 2 | 2017 | 334 | 0.250 |
Why?
|
Antigens, Neoplasm | 3 | 2017 | 1998 | 0.230 |
Why?
|
Mutation | 12 | 2021 | 29932 | 0.220 |
Why?
|
Killer Cells, Natural | 4 | 2024 | 2203 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2024 | 4550 | 0.200 |
Why?
|
T-Box Domain Proteins | 1 | 2023 | 468 | 0.180 |
Why?
|
Brain Neoplasms | 4 | 2024 | 8986 | 0.180 |
Why?
|
Genome, Fungal | 3 | 2012 | 203 | 0.180 |
Why?
|
Binding, Competitive | 1 | 2021 | 1142 | 0.180 |
Why?
|
Oxidative Stress | 1 | 2011 | 3106 | 0.170 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 286 | 0.170 |
Why?
|
Neuroma, Acoustic | 1 | 2024 | 459 | 0.170 |
Why?
|
Tumor Microenvironment | 5 | 2024 | 3844 | 0.160 |
Why?
|
Transcription Factors | 5 | 2023 | 12103 | 0.160 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2022 | 5649 | 0.160 |
Why?
|
Mitochondria | 1 | 2011 | 3600 | 0.150 |
Why?
|
Genes, MHC Class II | 1 | 2018 | 451 | 0.150 |
Why?
|
Recurrence | 5 | 2022 | 8482 | 0.150 |
Why?
|
Immunologic Memory | 1 | 2024 | 1354 | 0.150 |
Why?
|
Gene Expression Profiling | 6 | 2019 | 9411 | 0.130 |
Why?
|
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 2 | 2012 | 28 | 0.130 |
Why?
|
DNA-Binding Proteins | 2 | 2012 | 9585 | 0.130 |
Why?
|
Haploinsufficiency | 1 | 2017 | 329 | 0.130 |
Why?
|
Immunotherapy, Active | 1 | 2015 | 59 | 0.120 |
Why?
|
Blood Cells | 1 | 2017 | 305 | 0.120 |
Why?
|
HLA-A2 Antigen | 1 | 2015 | 211 | 0.120 |
Why?
|
Sulfonamides | 1 | 2024 | 1977 | 0.120 |
Why?
|
Hematopoietic Stem Cells | 2 | 2017 | 3387 | 0.110 |
Why?
|
Immunity, Innate | 2 | 2023 | 3047 | 0.110 |
Why?
|
Immune System Diseases | 1 | 2016 | 258 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1375 | 0.110 |
Why?
|
Meningioma | 1 | 2022 | 1221 | 0.110 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3758 | 0.110 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2016 | 640 | 0.110 |
Why?
|
Meningeal Neoplasms | 1 | 2022 | 1249 | 0.110 |
Why?
|
Genes, Fungal | 2 | 2011 | 439 | 0.110 |
Why?
|
Chromosome Segregation | 1 | 2013 | 233 | 0.100 |
Why?
|
Cytokines | 2 | 2024 | 7343 | 0.100 |
Why?
|
Microbial Viability | 1 | 2013 | 238 | 0.100 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2414 | 0.100 |
Why?
|
Point Mutation | 1 | 2017 | 1594 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1889 | 0.100 |
Why?
|
RNA Splicing | 1 | 2016 | 915 | 0.090 |
Why?
|
Epitopes | 1 | 2017 | 2503 | 0.090 |
Why?
|
Gene Expression | 2 | 2020 | 7588 | 0.090 |
Why?
|
Bone Marrow | 2 | 2016 | 2912 | 0.080 |
Why?
|
Glucose | 2 | 2011 | 4351 | 0.080 |
Why?
|
Transcription, Genetic | 4 | 2012 | 7593 | 0.080 |
Why?
|
Computational Biology | 2 | 2016 | 3505 | 0.080 |
Why?
|
Quantitative Trait Loci | 1 | 2016 | 2101 | 0.070 |
Why?
|
Phospholipids | 1 | 2011 | 789 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11712 | 0.070 |
Why?
|
Cancer Vaccines | 1 | 2015 | 1046 | 0.070 |
Why?
|
DNA Replication | 1 | 2013 | 1412 | 0.070 |
Why?
|
Phosphates | 1 | 2010 | 772 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2919 | 0.070 |
Why?
|
DNA Methylation | 1 | 2020 | 4373 | 0.060 |
Why?
|
Transcriptional Activation | 1 | 2011 | 1755 | 0.060 |
Why?
|
Humans | 25 | 2024 | 760621 | 0.060 |
Why?
|
Ultrasonography | 1 | 2018 | 5961 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4713 | 0.060 |
Why?
|
Genotype | 1 | 2019 | 12960 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3610 | 0.060 |
Why?
|
Gene Deletion | 1 | 2012 | 2668 | 0.060 |
Why?
|
Immunity | 2 | 2022 | 998 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2019 | 15789 | 0.060 |
Why?
|
Phenotype | 2 | 2019 | 16546 | 0.060 |
Why?
|
Dendritic Cells | 1 | 2015 | 2725 | 0.060 |
Why?
|
Genomics | 1 | 2019 | 5794 | 0.050 |
Why?
|
Mice | 8 | 2023 | 81208 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2024 | 11903 | 0.050 |
Why?
|
Schwann Cells | 1 | 2024 | 196 | 0.050 |
Why?
|
Cell Cycle | 1 | 2011 | 2934 | 0.050 |
Why?
|
Transplantation, Homologous | 2 | 2022 | 4810 | 0.050 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10181 | 0.050 |
Why?
|
Glycolysis | 1 | 2005 | 828 | 0.050 |
Why?
|
Genetic Variation | 1 | 2016 | 6551 | 0.050 |
Why?
|
Meninges | 1 | 2022 | 197 | 0.040 |
Why?
|
Ecosystem | 1 | 2024 | 485 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2015 | 1737 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 705 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 1088 | 0.040 |
Why?
|
Animals | 8 | 2023 | 167963 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2023 | 820 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1837 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 1617 | 0.030 |
Why?
|
Ubiquitination | 1 | 2021 | 1008 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2005 | 1902 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2023 | 1411 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8651 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2627 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2017 | 297 | 0.030 |
Why?
|
Melanoma | 1 | 2015 | 5697 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2016 | 146 | 0.030 |
Why?
|
Idarubicin | 1 | 2015 | 59 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2018 | 749 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17790 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5799 | 0.030 |
Why?
|
Daunorubicin | 1 | 2015 | 156 | 0.030 |
Why?
|
Monitoring, Immunologic | 1 | 2015 | 98 | 0.030 |
Why?
|
MAP Kinase Signaling System | 2 | 2017 | 1484 | 0.030 |
Why?
|
Microglia | 1 | 2023 | 1351 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2017 | 1753 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2018 | 1529 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3616 | 0.030 |
Why?
|
Cytarabine | 1 | 2015 | 696 | 0.030 |
Why?
|
Cell Line | 2 | 2017 | 15620 | 0.030 |
Why?
|
Genome, Human | 2 | 2016 | 4417 | 0.030 |
Why?
|
Models, Genetic | 1 | 2002 | 3442 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2021 | 3735 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4264 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2023 | 3707 | 0.030 |
Why?
|
Myo-Inositol-1-Phosphate Synthase | 1 | 2011 | 2 | 0.030 |
Why?
|
Female | 9 | 2024 | 391270 | 0.020 |
Why?
|
Galactokinase | 1 | 2011 | 17 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2020 | 2693 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2015 | 801 | 0.020 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 1 | 2012 | 169 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2913 | 0.020 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 151 | 0.020 |
Why?
|
F-Box Proteins | 1 | 2012 | 202 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2020 | 2050 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2017 | 1765 | 0.020 |
Why?
|
S-Adenosylmethionine | 1 | 2011 | 213 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2022 | 4353 | 0.020 |
Why?
|
Signal Transduction | 2 | 2024 | 23376 | 0.020 |
Why?
|
Oscillometry | 1 | 2010 | 145 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21025 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 1728 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2015 | 1254 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3539 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3584 | 0.020 |
Why?
|
Methylation | 1 | 2011 | 1082 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2011 | 802 | 0.020 |
Why?
|
Macrophages | 1 | 2023 | 5745 | 0.020 |
Why?
|
Lymphocytes | 1 | 2016 | 2611 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2018 | 5870 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3817 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2015 | 12766 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9530 | 0.020 |
Why?
|
Ubiquitin | 1 | 2012 | 838 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11481 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22072 | 0.020 |
Why?
|
Male | 6 | 2024 | 359744 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6828 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2015 | 4291 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 220352 | 0.020 |
Why?
|
Adult | 4 | 2024 | 219994 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11071 | 0.010 |
Why?
|
Chromatin | 1 | 2016 | 2938 | 0.010 |
Why?
|
Estradiol | 1 | 2011 | 1932 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2506 | 0.010 |
Why?
|
Binding Sites | 1 | 2012 | 6048 | 0.010 |
Why?
|
Aged | 3 | 2024 | 169152 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 1741 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12808 | 0.010 |
Why?
|
Computer Simulation | 1 | 2016 | 6218 | 0.010 |
Why?
|
Cell Membrane | 1 | 2011 | 3682 | 0.010 |
Why?
|
Software | 1 | 2016 | 4419 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2011 | 2981 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5785 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18957 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9335 | 0.010 |
Why?
|
MicroRNAs | 1 | 2015 | 3790 | 0.010 |
Why?
|
Protein Interaction Mapping | 1 | 2002 | 617 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2010 | 2869 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18137 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 65017 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 12626 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5791 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29658 | 0.010 |
Why?
|
Child | 1 | 2022 | 79806 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9467 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 54303 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2016 | 58995 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 87810 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 74359 | 0.010 |
Why?
|